Nasal flu vaccine response in healthy adults
Part of Infections, Lungs & breathing clinical trials.
This trial studies how healthy adults respond to the nasal flu vaccine (FluMist). It aims to understand immune responses and may help improve future flu vaccines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have not smoked or vaped in the last 6 months.
- You do not have chronic lung disease or other significant long-term health conditions.
- You have not had a cold or respiratory infection in the last month.
- You have not received the current flu vaccine this season.
- You are willing to follow study procedures and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system (your body’s infection-fighting system) responds during and around the time of a flu illness. It’s meant to help researchers better understand immune changes in healthy adults and may guide future flu care.
This study tests a new flu vaccine in adults aged 65 and older to see how well it prevents the flu. If you are generally healthy or manage chronic conditions well, you may be able to join.
This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.
This study tests how the immune system in your nose and airways responds to the FluMist nasal spray flu vaccine. It may help doctors understand why some people get better protection from the flu.
This trial tests a flu vaccine given as a nasal spray instead of a shot. It aims to see how well it protects adults aged 18 to 59 from getting the flu.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
Hear when a new Mucosal Immune Response to Influenza Vaccination trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.